Evidence map›Paper›PMID 30692207›Full record

ArticleGenes & development2019

A ZNRF3-dependent Wnt/β-catenin signaling gradient is required for adrenal homeostasis.

Kaitlin J Basham, Stéphanie Rodriguez, Adina F Turcu, Antonio M Lerario, Catriona Y Logan, Madeline R Rysztak, Celso E Gomez-Sanchez, David T Breault, Bon-Kyoung Koo, Hans Clevers and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Adrenocortical stem cells in health and disease.Nature reviews. Endocrinology · 2025
    Review
  6. Review
  7. Article
  8. Wnt signalosomes: What we know that we do not know.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 4 countries.

Kaitlin J BashamDepartment of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan 48109, USA.
Stéphanie RodriguezGénétique Reproduction et Développement (GReD), UMR 6293, Centre National de la Recherche Scientifique (CNRS), U1103, Institut National de la Santé et de la Recherche Médicale (INSERM), Université Clermont Auvergne, 63001 Clermont-Ferrand Cedex, France.
Adina F TurcuDepartment of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan 48109, USA.
Antonio M LerarioDepartment of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan 48109, USA.
Catriona Y LoganDepartment of Developmental Biology, Howard Hughes Medical Institute, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.
Madeline R RysztakDepartment of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan 48109, USA.
Celso E Gomez-SanchezDepartment of Medicine, University of Mississippi Medical Center, Jackson, Mississippi 39216 USA.
David T BreaultDivision of Endocrinology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
Bon-Kyoung KooInstitute of Molecular Biotechnology, Vienna 1030, Austria.
Hans CleversHubrecht Institute for Developmental Biology and Stem Cell Research, University Medical Centre Utrecht, 3584CT Utrecht, The Netherlands.
Roeland NusseDepartment of Developmental Biology, Howard Hughes Medical Institute, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.
Pierre ValGénétique Reproduction et Développement (GReD), UMR 6293, Centre National de la Recherche Scientifique (CNRS), U1103, Institut National de la Santé et de la Recherche Médicale (INSERM), Université Clermont Auvergne, 63001 Clermont-Ferrand Cedex, France.
Gary D HammerDepartment of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan 48109, USA.
University of Michigan–Ann Arbor · USBoston Children's Hospital · USCentre National de la Recherche Scientifique · FRHoward Hughes Medical Institute · USHubrecht Institute for Developmental Biology and Stem Cell Research · NLInstitute of Molecular Biotechnology · ATStanford University · USUniversité Clermont Auvergne · FRUniversity of Mississippi Medical Center · US

Funding

Mechanisms of Adrenal DifferentiationR01DK062027 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GARY D. HAMMER · 2004 to 2026
$8.0M
MECHANISMS LEADING TO ADRENAL ZONATIONR01DK043140 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI William E Rainey · 1999 to 2026
$7.2M
Postdoc Stipend Supplement: Developmental Origins of Metabolic Disorders T32T32DK071212 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON, Kanakadurga Singer · 2005 to 2026
$5.4M
Wnt-responsive adrenocortical cells in organ maintenance and cancerR01CA134606 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAMMER, GARY D. · 2010 to 2014
$1.4M
NCI NIH HHS R01 CA134606NIDDK NIH HHS R01 DK043140NIDDK NIH HHS R01 DK062027NIDDK NIH HHS T32 DK071212
6 · The paper itself

Abstract

Spatiotemporal control of Wnt signaling is essential for the development and homeostasis of many tissues. The transmembrane E3 ubiquitin ligases ZNRF3 (zinc and ring finger 3) and RNF43 (ring finger protein 43) antagonize Wnt signaling by promoting degradation of frizzled receptors. ZNRF3 and RNF43 are frequently inactivated in human cancer, but the molecular and therapeutic implications remain unclear. Here, we demonstrate that adrenocortical-specific loss of ZNRF3, but not RNF43, results in adrenal hyperplasia that depends on Porcupine-mediated Wnt ligand secretion. Furthermore, we discovered a Wnt/β-catenin signaling gradient in the adrenal cortex that is disrupted upon loss of ZNRF3. Unlike β-catenin gain-of-function models, which induce high Wnt/β-catenin activation and expansion of the peripheral cortex, ZNRF3 loss triggers activation of moderate-level Wnt/β-catenin signaling that drives proliferative expansion of only the histologically and functionally distinct inner cortex. Genetically reducing β-catenin dosage significantly reverses the ZNRF3-deficient phenotype. Thus, homeostatic maintenance of the adrenal cortex is dependent on varying levels of Wnt/β-catenin activation, which is regulated by ZNRF3.

Indexed as

Adrenal CortexAdrenal Cortex DiseasesAnimalsbeta CateninCell ProliferationFemaleGene Knockout TechniquesHomeostasisMaleMiceModels, AnimalTranscriptional ActivationUbiquitin-Protein LigasesWnt Signaling Pathwaybeta CateninUbiquitin-Protein LigasesZnrf3 protein, mouseadrenal zonationmouse modelsorgan maintenanceproliferationWnt signaling

Identifiers

PMID30692207
PMCPMC6362817
OpenAlexW2912378470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.